EnteroSatys Metabolism is based on Hafnia alvei combined in a patented formulation with zinc and chromium, for the EU claim contributes to the normal metabolism of macronutrients (glucids and lipids). It is a premium, highly stable (36 months at room temperature) probiotic available for distribution in many countries.
EnteroSatys / Satylia Read More »
Constipation • Intestinal transit • Anti-inflammatory • Reduction of gastro-intestinal discomfort • Inhibition of pathogenic E. coli • Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction
Bifidobacterium breve – BR03 (DSM 16604) Read More »
Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cholesterol management
Bifidobacterium longum – 04 (DSM 23233) Read More »
Weight management • Vaginal health • Rebalance of a healthy vaginal microbiota
Lactobacillus gasseri – LGS06 (DSM 32405) Read More »
L. rhamnosus HA-114 is an innovative patent-pending probiotic strain able to improve eating and mood-related behaviors in overweight adults undergoing a diet-induced weight loss. It could favor wellness and facilitate adherence during a diet-based weight reduction program, through its action on the brain-gut axis. L. rhamnosus HA-114 supports weight management efforts during a diet (eating
Lacticaseibacillus rhamnosus HA-114 Read More »
Hafnia alvei is the first precision probiotic developed based on a target-based approach and a screening for strains producing ClpB, a protein mimicking alpha-MSH and activating the signals of satiety. Its mechanism of action and demonstration in efficacy in mice and humans make it a uniquely positioned, innovative next-gen probiotic for weight management.
Hafnia alvei HA4597 Read More »
MicrobiomeHUB is a space that brings together the companies of the microbiome industry
Brought to you by Clorofilla Scientific Publishing
This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED
